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FAMILIAL CLUSTERING OF CANCER IN TWO TERTIARY CARE HOSPITALS IN
NAIROBI, KENYA
G. W. KIARIE, N. O. ABINYA, M. D. JOSHI, G. N. LULE and G. Z. MUTUMA
ABSTRACT
Objective: To describe the occurrence of cancers in families of individuals diagnosed
cancer.
Design: Cross-sectional descriptive study.
Setting: Outpatient cancer clinics at Kenyatta National Hospital (KNH) and Radiotherapy
Clinic at Nairobi Hospital.
Subjects: Patients with a tissue histological or cytological diagnosis of cancer.
Main outcome measures: A reported family history of cancer.
Results: A total number of 485 cancer patients were recruited, 382, from KNH and 103
from Nairobi Hospital. These index cases had 45 different types of cancer, with the
most common being breast and uterine-cervical malignancies. Prevalence of family
history of cancer was found to be 18.8% and was highest among 1st degree relatives.
Documentary evidence was seen in 48.4% and history of cancer corroborated by
medical personnel in an additional 11%. In 18.7% of cases more than one relative was
interviewed to conﬁrm the family history of cancer. Educational levels of the index
cases correlated with knowledge of family history of cancer, with those of higher
educational level having been more informed about their families’ medical history.
There was a prevalence of familial cancers of 30% at Nairobi Hospital patients and
15.7% at KNH patients.
Conclusion: We found the prevalence of family history of cancer in our population to
be 18.8% and was highest among 1st degree relatives. This has implications for targeted
screening and therefore early diagnosis which is beneﬁcial.
INTRODUCTION
Cancer is a major cause of morbidity and mortality
in developed countries and of increasing concern in
developing countries. Its treatment is often costly and
associated with high mortality, whereas screening
and early diagnosis is life saving.
Epidemiological surveys indicate that patients
with certain cancers often have a family history of
cancer (1). Familial cancers with clear patterns of
mendelian inheritance are very rare. However in the
past decade many genes responsible for these rare
disorders have been identiﬁed (1).
The cancer genes characterised and known
inheritance patterns are associated with speciﬁc cancer
syndromes comprising two or more malignancies
in “cancer families”. Targeted genetic testing and
screening of susceptible individuals is being carried

out in developed countries. For example it has been
found that screening and genetic testing (for BRCA 1
and 2 genetic markers) reduces breast cancer mortality
and has important implications in the natural history
of the disease. Evidence suggests that metastases
occur very early in breast cancer and it should be
considered a systemic disease from the onset due
to delay in diagnosis of majority of cases. Studies
show that targeted surveillance, therefore earlier
screening of women with a family history of breast
cancer leads to improved survival (2). Breast cancer
is the most common malignancy in women in Kenya
making up 23.3% of women cancers (3). In the Kenyan
woman, it occurs more in premenopausal ages, is a
more aggressive disease presenting with metastases
in 88% of the cases, with higher grades but similar
histological types to white women (4). There is lower
postitivity both endochrine receptors and Her/neu 2
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receptors (5), which correlates with poorer prognosis.
African American women have similar poor prognostic
indicators and a 37% higher mortality than white
women, in whom early referral and treatment is aimed
at (6). In our setup high risk individuals from “cancer
families” can undergo targeted screening that can be
cost effective and life saving.
MATERIALS AND METHODS
Cases were recruited from KNH medical, surgical and
radiotherapy outpatient clinics and Nairobi Hospital’s
radiotherapy unit. Most cancer patients seen at KNH
were outpatients due to the hospital policy of limiting
admission of chronic patients. KNH inpatients were not
included because of logistics of covering all the wards,
difﬁculty in consecutive sampling of inpatients and
potential for selection bias. The KNH radiotherapy clinic
operates as outpatient oncology follow-up clinic.
Inclusion and exclusion criteria: Patients with a
documented diagnosis of cancer who consented to
participation in the study were recruited. Secondary
malignancies, such as HIV and post-transplant
associated cancers were excluded.
Two research assistants assisted in screening the
daily clinic attendance ﬁles for histological report
of cancer. These patients were approached using a
standardised information sheet. A written informed
consent was obtained.
The principal investigator administered a
standardised questionnaire to all the index cases
and accompanying relatives. If no relative had
accompanied the patient, their relatives were contacted
and interviewed. A follow-up was made to interview
other relatives who corroborated the presence or
absence of a family history of cancer. Contact telephone
numbers and addresses of relatives to be interviewed
were provided by the index cases.
Cancer type and demographic details of the index
case were documented. Family history of cancer in
patient’s ﬁrst and second degree relative was sought.
A detailed family medical history of these relatives
was taken. An “important-other” family member,
based on educational level, prominence and inﬂuence
in the family and a willingness to cooperate with
the investigator, was identiﬁed and interviewed in
person, via telephone or mail, seeking to conﬁrm
the family history as reported by index case and
accompanying relatives. Cancer type, institution
where diagnosis was made, attending physician, year
of diagnosis, follow-up clinic as well as demographics
of the other relative with cancer were noted. This
helped in accessing documentary evidence of the
same. If alive the relative with cancer was interviewed
in person or via telephone contact.
Documentary evidence of the relatives’
with cancer was also sought from the existing
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cancer registries in KNH and KEMRl (Kenya
Medical Research Institute), other hospital records,
death certiﬁcates, pathology reports and verbal
corroboration from attending physicians were sought.
Consequently the level of evidence, of a family history
of cancer was categorised on basis of level of cross
validation as follows:
Conﬁrmed: Documentary evidence obtained ,such
as hospital discharge summaries, record cards, DXT
cards ,histology reports, prescriptions and perusal
of attending physicians’ notes.
Highly probable: Verbal conﬁrmation of history by
relatives who were medical for example doctors, clinical
ofﬁcers or nurses, as well attending physicians.
Probable: Verbal corroboration from patient and
two other relatives including the “important-other
relative”.
Least probable: Verbal conﬁrmation from patient
and any other relative.
RESULTS
Five hundred and thirteen cases were screened and 485
were recruited during the period of June to November
2003; 78.8% of sample from KNH, and 21.2% from
Nairobi Hospital. Male to female ratio was 1:1.5 and
age ranged from 13 to 93 years, with 44% in the 31 to 50
years age group and 16.7% in 60 to 80 years. Sixty eight
per cent drawn from rural and 32% from urban areas.
They were mainly from Central province, followed by
Nyanza, Eastern and Coast provinces. This follows
the referral patterns of outpatients attending clinics
in KNH. The ethnicity of index cases also follows
the catchments area of the two hospitals implying
unbiased sampling.
Educational levels of the index cases were: 17.3%
no formal education, 37.7% primary, 28.7% secondary
and 16.3% tertiary level. The Nairobi Hospital cohort
had higher levels of formal education while 64% of
KNH cohort had primary level education or had
received no formal education at all.
Index cases had 45 different cancer types, with
the most frequent being breast (13.8%) and uterine
cervix (14%). Post-nasal tumour (11%), skin cancers
(6.9%), non PNS head and neck tumours (6%) and
laryngeal cancers 5%.
A prevalence of family history of cancer was
established in 18.8% (95% C.I 15 22%). Prevalence of
positive family history was 12.4% among 1st degree
relatives and 6.4% in 2nd degree relatives. Some
families had a multiple family history of cancer; 25%
had more than one relative with cancer, two cases
had four relatives each with cancer. A total of 125
relatives had cancer from 91 index cases
Family history of cancer was validated as conﬁrmed
or highly probably in 59.4% of cases (Table 1). On
stratifying according to hospital and educational level
of index cases, a higher prevalence of positive family
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history was found among those of higher educational
attainment and among the Nairobi Hospital cohort
(30%; 95% CI 0.55.20), in contrast to the prevalence in
the KNH cohort ( 5.7% (CI 0.54-.20) (Table 2).
Table 1
Prevalence of a family history of cancer according to
institution and education level
Hospitals/ KNH KNH FHx
Education
of
Level
cancer
None
70
6
Primary
176
7
Secondary 107
24
Tertiary
29
23
Total
382 60 (15.7%)

NRB
Hosp
14
7
32
50
103

NRB
FHX of
cancer
2
5
8
16
31 (30%)
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Approximately 16.8% of relatives were living, half
of whom were interviewed, while 83.2% were dead.
Relatives with cancer had an age distribution skewed
to the right and majority were aged over 60 years
(Figure 1) and of male gender (54%).
There were 61% ﬁrst degree relatives and 39%
second degree relatives among the relatives with
cancer. Of the 66 breast cancer index cases 36% had
a family history of cancer; 66% were ﬁrst degree
relatives and 34% were second degree relatives.
There were 67 index cases with cancer of cervix, of
these 21% had a family history of cancer and 43%
were ﬁrst degree relatives and 58.2% second degree
relatives. There were 125 relatives with 24 different
cancers, the most common being cancers of uterine
cervix and breast; a frequency pattern similar to that
of index cases (Figure 2).

Table 2
Differences in familial clustering in the breast cancer and uterine cervix cancer
Cancer type

Cancer of
breast
24 (36%)
42
66

Family HX of CA
No Family HX of CA
Total

Cancer of
cervix
14 (21%)
53
67

Cancer PNS

Total

7 (13%)
46
53

45
141
186

Chi - Square Calculation:
Degrees of freedom 2
Chi - square =9.21511699921617
X2= 9.2 P<0.01
This distribution is signiﬁcant
Figure 1
Age distribution of relatives with cancer
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Figure 2
The common cancer types among relatives of index cases
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DISCUSSION
We found a prevalence of familial clustering of cancer
of 18.8% (95% C.I 15 - 22%). This is the ﬁrst such data
in this region, as no data is available for sub-Saharan
Africa but our data correlated with Western data in
several areas. The general population risk for various
malignancies ranges from 5 -25% (7,8). In Utah and
California combined data on 44,788 pairs of twins
showed increased familial risk among twins of
patients with stomach, colorectal, lung, prostate and
breast malignancies (9). We found a familial clustering
of 36% in breast cancer patients, while a Stockholm
study showed 35% in breast cancer as well, with a
younger age of onset in the familial group (10). All
these studies used cancer registry data in contrast
to recall as utilised in our study. Our ﬁnding may be
an underestimate due to the various biases limiting
veriﬁcation of the family history of cancer. Recall
bias was a major shortcoming of this study. Under
reporting on account of illiteracy, lack of inter-family
communication, geographical constraints, stigma
of the disease and conﬁdentiality issues can be
expected to have biased our ﬁnding to the null. Poor
record keeping and lack of updated cancer registries,
limited veriﬁcation of the information obtained. Over
estimating on account of misclassiﬁcation bias was
minimised by veriﬁcation of information at various
levels. Limiting the analysis to veriﬁed conﬁrmed
family history of cancer gave a prevalence’s similar
to those in studies in which cancer registries were
utilised.
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Survival bias limited recruitment of cancer types
that are rapidly fatal, as depicted by only three cases
of hepatocellular cancer yet it is among the top ﬁve
malignancies in our country.
Our ﬁndings are generalisable to the Kenya
cancer population; ﬁrstly because our sample was
unbiased, as is evident from the similar national cancer
frequencies (11) and demographics of the index cases
to those of other chronic disease patients attending
outpatient clinics at the KNH (12). Secondly, KNH is
the only national cancer referral treatment centre and
third, the general population lack of awareness about
possible familial clustering of cancer is not expected
to have contributed signiﬁcantly to a referral bias.
As reported in European studies, we documented
a higher prevalence in ﬁrst degree as apposed to
second degree relatives, and we view this as further
validation evidence (13). In some studies monozygotic
twins have higher cancer risk than dizygotic twins
of cancer patients (14).
Uterine cervical cancer in our sample did not have
a strong familial predilection as has been similarly
reported in epidemiological data from the US and
Europe with the occurrence being predicted more
by environmental factors such as number of sexual
partners, age at ﬁrst intercourse and HPV infection
(15). Investigators reporting clustering of cervical
cancer in families have argued that these individuals
shared the same environment and have common
lifestyle patterns hence tendency to be infected with
HPV (16).
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Whereas cancer is generally a disease of the
elderly population, due to increased susceptibility
as duration of exposure to carcinogens increases,
the relatively younger age distribution in our study
is a reﬂection of higher frequency of early occurring
female gender cancers. In Western literature the
common associations of parity, early age of delivery
were not protective against ovarian cancer in those
with a strong family history of cancer (17).
In conclusion we found a prevalence of familial
clustering of cancer s in our setup to be approximately
18.8% and is highest amongst ﬁrst-degree relatives
at 12% compared to 6% for second-degree relatives.
Breast cancer had a familial clustering prevalence
of 36% and a same cancer concordance rate of 54%.
Multiple family history of cancer was highest in
breast cancer cases. If an early diagnosis of cancers is
made, many lives can be saved and cost of treatment
reduced. An awareness of familial risk of cancer is
important towards this end. Targeted screening of
these family members will aid in early diagnosis and
therefore reduce morbidity and mortality of the two
most common malignancies in our environment.
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